Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 200B (TMEM200B) is a protein-coding gene predicted to encode a membrane protein, with localization in cell membranes as part of the DUF2371 (domain of unknown function 2371) family. Its precise molecular and biological functions in humans are unknown, and there is no direct evidence of it acting as a receptor, transporter, or enzyme. Some expression is noted across tissues, and genetic association exists with anal canal squamous cell carcinoma, but its mechanistic involvement in disease remains unclear. There are no established biomarkers or drugs clinically targeting TMEM200B, and no direct safety or therapeutic data are described[1][3][5][8][9][10].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 200B (TMEM200B).